Quality assurance of magnetic resonance spectroscopic imaging-derived metabolic data

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 4, 2003, Pages 1159-1173

  Hunjan, Sandeep ^a,b   Adalsteinsson, Elfar ^a   Kim, Dong Hyun ^a   Harsh, Griffith R ^a   Boyer, Arthur L ^a   Spielman, Daniel ^a   Xing, Lei ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

MRS; MRSI; Phantom; Quality assurance

Indexed keywords

CONCENTRATION (PROCESS); METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; QUALITY ASSURANCE; REGRESSION ANALYSIS; TUMORS;

METABOLIC INFORMATIONS;

RADIOTHERAPY;

ACCURACY; AQUEOUS SOLUTION; ARTICLE; BRAIN TUMOR; CALCULATION; CALIBRATION; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER PROGRAM; CORRELATION COEFFICIENT; DATA ANALYSIS; EVALUATION; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHANTOM; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; TREATMENT PLANNING;

EID: 0142248767     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)01564-5     Document Type: Article

References (38)

1. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT) Biological imaging and biological conformality. [see comments] Int J Radiat Oncol Biol Phys. 47:2000;551-560.
2. Xing L., Cotrutz C., Hunjan S., et al. Inverse planning for functional image guided intensity modulated radiation therapy. Phys Med Biol. 47:2002;3567-3578.
3. Merchant T.E. MR spectroscopy of the breast. Magn Reson Imaging Clin N Am. 2:1994;691-703.
4. Miller B.L. A review of chemical issues in 1H NMR spectroscopy N-acetyl-L-aspartate, creatine and choline. NMR Biomed. 4:1991;47-52.
5. Miller B.L., Chang L., Booth R., et al. In vivo 1H MRS choline Correlation with in vitro chemistry/histology. Life Sci. 58:1996;1929-1935.
6. Kurhanewicz J., Vigneron D.B., Hricak H., et al. Prostate cancer Metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology. 200:1996;489-496.
7. 3) spatial resolution. Radiology. 198:1996;795-805.
8. Heerschap A., Jager G.J., van der Graaf M., et al. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res. 17:1997;1455-1460.
9. van Zijl P.C., Moonen C.T., Gillen J., et al. Proton magnetic resonance spectroscopy of small regions (1 mL) localized inside superficial human tumors. A clinical feasibility study. NMR Biomed. 3:1990;227-232.
10. Roebuck J.R., Cecil K.M., Schnall M.D., et al. Human breast lesions Characterization with proton MR spectroscopy. Radiology. 209:1998;269-275.
11. Mackinnon W.B., Barry P.A., Malycha P.L., et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology. 204:1997;661-666.
12. Gribbestad I.S., Singstad T.E., Nilsen G., et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging. 8:1998;1191-1197.
13. Star-Lack J., Vigneron D.B., Pauly J., et al. Improved solvent suppression and increased spatial excitation bandwidths for three-dimensional PRESS CSI using phase-compensating spectral/spatial spin-echo pulses. J Magn Reson Imaging. 7:1997;745-757.
14. Adalsteinsson E., Irarrazabal P., Topp S., et al. Volumetric spectroscopic imaging with spiral-based k-space trajectories. Magn Reson Med. 39:1998;889-898.
15. Rabinov J.D., Lee P.L., Barker F.G., et al. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects Initial experience. Radiology. 225:2002;871-879.
16. Dydak U., Weiger M., Pruessmann K.P., et al. Sensitivity-encoded spectroscopic imaging. Magn Reson Med. 46:2001;713-722.
17. Wald L.L., Moyher S.E., Day M.R., et al. Proton spectroscopic imaging of the human brain using phased array detectors. Magn Reson Med. 34:1995;440-445.
18. Pirzkall A., McKnight T.R., Graves E.E., et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys. 50:2001;915-928.
19. Kurhanewicz J., Vigneron D.B., Nelson S.J. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia (NY). 2:2000;166-189.
20. Dowling C., Bollen A.W., Noworolski S.M., et al. Preoperative proton MR spectroscopic imaging of brain tumors Correlation with histopathologic analysis of resection specimens. [see comments] AJNR Am J Neuroradiol. 22:2001;604-612.
21. Nelson S.J., Graves E., Pirzkall A., et al. In vivo molecular imaging for planning radiation therapy of gliomas An application of 1H MRSI. J Magn Reson Imaging. 16:2002;464-476.
22. Negendank W. Studies of human tumors by MRS A review. NMR Biomed. 5:1992;303-324.
23. Alger J.R., Frank J.A., Bizzi A., et al. Metabolism of human gliomas Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. [see comments] Radiology. 177:1990;633-641.
24. Wald L.L., Nelson S.J., Day M.R., et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg. 87:1997;525-534.
25. Pirzkall A., Nelson S.J., McKnight T.R., et al. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys. 53:2002;1254-1264.
26. McKnight T.R., von dem Bussche M.H., Vigneron D.B., et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg. 97:2002;794-802.
27. Hunjan S., Harsh G., Gibbs I., et al. Validating magnetic resonance spectroscopic imaging for radiation therapy guidance. [Abstract] Proc Am Soc Therap Radiol Oncol. 54:(Suppl. 2):2002;29.
28. Frahm J., Bruhn H., Gyngell M.L., et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med. 11:1989;47-63.
29. Michaelis T., Merboldt K.D., Bruhn H., et al. Absolute concentrations of metabolites in the adult human brain in vivo Quantification of localized proton MR spectra. [Erratum appears in Radiology 1993;188:288] Radiology. 187:1993;219-227.
30. Pouwels P.J., Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med. 39:1998;53-60.
31. Pfeuffer J., Tkac I., Provencher S.W., et al. Toward an in vivo neurochemical profile Quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magnet Resonance. 141:1999;104-120.
32. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci. 508:1987;333-348.
33. Drost D.J., Riddle W.R., Clarke G.D., et al. Proton magnetic resonance spectroscopy in the brain Report of AAPM MR Task Group #9. Med Phys. 29:2002;2177-2197.
34. Haase A., Frahm J., Hanicke W., et al. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol. 30:1985;341-344.
35. Spielman D.M., Adalsteinsson E., Lim K.O. Quantitative assessment of improved homogeneity using higher-order shims for spectroscopic imaging of the brain. Magn Reson Med. 40:1998;376-382.
36. Kim D.H., Adalsteinsson E., Glover G.H., et al. Regularized higher-order in vivo shimming. Magn Reson Med. 48:2002;715-722.
37. Jackson J.I., Mayer C.H., Nishimura D.G., et al. Selection of a convolution function for fourier inversion using gridding. IEEE Trans Med Imag. 10:1991;473-478.
38. McKnight T.R., Noworolski S.M., Vigneron D.B., et al. An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imaging. 13:2001;167-177.